Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in childr...
Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children
About this item
Full title
Author / Creator
Flare Reduction in Eczema with Elidel (Children) Multicenter Investigator Study Group , for the Flare Reduction in Eczema with Elidel (Children) Multicenter Investigator Study Group , Wahn, Ulrich , Bos, Jan D , Goodfield, Mark , Caputo, Ruggero , Papp, Kim , Manjra, Ahmed , Dobozy, Attila , Paul, Carle , Molloy, Stephen , Hultsch, Thomas , Graeber, Michael , Cherill, Robert and de Prost, Yves
Publisher
United States: American Academy of Pediatrics
Journal title
Language
English
Formats
Publication information
Publisher
United States: American Academy of Pediatrics
Subjects
More information
Scope and Contents
Contents
Pimecrolimus cream (SDZ ASM 981), a nonsteroid inhibitor of inflammatory cytokines, is effective in atopic dermatitis (AD). We assessed whether early treatment of AD signs/symptoms with pimecrolimus could influence long-term outcome by preventing disease flares.
Early intervention with pimecrolimus was compared with a conventional AD treatment s...
Alternative Titles
Full title
Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children
Authors, Artists and Contributors
Author / Creator
for the Flare Reduction in Eczema with Elidel (Children) Multicenter Investigator Study Group
Wahn, Ulrich
Bos, Jan D
Goodfield, Mark
Caputo, Ruggero
Papp, Kim
Manjra, Ahmed
Dobozy, Attila
Paul, Carle
Molloy, Stephen
Hultsch, Thomas
Graeber, Michael
Cherill, Robert
de Prost, Yves
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_228321795
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_228321795
Other Identifiers
ISSN
0031-4005
E-ISSN
1098-4275
DOI
10.1542/peds.110.1.e2
